Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status

Neuroendocrinology Letters

Volumn 29, Issue 4, 2008, Pages 461-466

  Masek, Martin ^a   Vaneckova, Manuela ^a   Krasensky, Jan ^a   Danes, Jan ^a   Havrdova, Eva ^a   Hrebikova, Tereza ^a   Seidl, Zdenek ^a  

^a Cardiovascular Medicine General Teaching Hospital   (Czech Republic)

Author keywords

Brain atrophy; Chronic progressive; Demyelinating autoimmune diseases; MRI; Multiple sclerosis; Relapsing remitting

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN TISSUE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; RECURRENT DISEASE; SIGNAL DETECTION; STATISTICAL SIGNIFICANCE;

EID: 54449095778     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bakshi R, Dandamundi VSR, Neema M, De C, Bermel RA (2005a). Measurment of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. J Neuroimaging. 15: 30-45.
2. Bakshi R, Minagar A, Jaisani Z, Wolinski JS (2005b). Imaging of multiple sclerosis: role in neurotherapeutics. NeurRx. 2: 277-303.
3. Dastidar P, Heinonen T, Lehtimaki T, Ukkonen M, Peltola J, Erila T (1999). Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiplce sclerosis. J Neurol Sci. 165: 36-42.
4. Fisher E, Rudick RA, Simon JH, Cutter G, Baier M, Lee JC, et al (2002). Eight-year follow-up study of brain atrophy in patients with MS. Neurology. 59: 1412-1420.
5. Giovannoni G (2004). Management of secondary-progressive multiple sclerosis. CNS Drugs. 18(10): 653-69.
6. Naismith R, Cross A (2005). Multiple sclerosis and black holes: connecting the pixies, Arch.Neurol. 62(11): 1666-8.
7. Prinster A, Quarantelli M, Orefice G (2006). Grey matter loss in relapsing-remitting multiple sclerosis: a voxel - based morphometry study. Neuroimage. 29(3): 859.
8. Sailer M, Losseff NA, Wang L, Gawne-Cain ML, Thompson AJ, Miller DA (2001). T1 leasion load and cerebral atrophy as a marker for clinical progression in patients with MS. A prospective 18 months follow up study. Eur J Neurol. 8(1): 37-42.
9. Tedeschi G, Lavorna L, Russo P (2005). Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology. 65(2): 280-5.
10. Vaneckova M, Seidl Z, Krasensky J, Obenberger J, Havrdova E, Vitak T, et al (2002). Lesion load in modus FLAIR (Fluid Attenuated Inversion Recovery) in patients with multiple sclerosis. Cesk Slov neurol N. 65(3): 175-179.
11. Zivadinov R, Bakshi R (2004). Role of MRI in multiple sclerosis I: inflammations and lesions. Front Biosci. 9: 665-683.
12. Zivadinov R, Leist TP (2005). Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging. 15: 10S-21S.